Literature DB >> 29484309

Balancing Autophagy for a Healthy Heart.

Mark A Lampert1, Åsa B Gustafsson1.   

Abstract

Autophagy is a well-known intracellular degradation process involved in clearing damaged or unnecessary components in cells. Functional autophagy is important for cardiac homeostasis. Given this, it is not surprising that dysregulation of autophagy has been implicated in the aging process and in various cardiovascular diseases. Therefore, understanding the functional role of autophagy in the heart under various conditions and whether manipulation of the pathway has therapeutic benefits have been a major focus of many investigations in recent years. Although consensus exists that autophagy is a critical cellular quality control pathway in the heart, its role in disease remains controversial. Whether altered autophagy is protective or detrimental in the heart seems to depend on the context and the disease. Here, we review the latest insights into autophagy in cardiovascular homeostasis and disease and its role in disease development.

Entities:  

Keywords:  Autophagy; aging; diabetes; heart disease

Year:  2017        PMID: 29484309      PMCID: PMC5824726          DOI: 10.1016/j.cophys.2017.11.001

Source DB:  PubMed          Journal:  Curr Opin Physiol        ISSN: 2468-8673


  47 in total

1.  APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p.

Authors:  Kun Wang; Cui-Yun Liu; Lu-Yu Zhou; Jian-Xun Wang; Man Wang; Bing Zhao; Wen-Ke Zhao; Shi-Jun Xu; Li-Hua Fan; Xiao-Jie Zhang; Chang Feng; Chao-Qun Wang; Yan-Fang Zhao; Pei-Feng Li
Journal:  Nat Commun       Date:  2015-04-10       Impact factor: 14.919

2.  Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes.

Authors:  Anne Hamacher-Brady; Nathan R Brady; Roberta A Gottlieb
Journal:  J Biol Chem       Date:  2006-08-01       Impact factor: 5.157

3.  Pharmacological modulation of autophagy to protect cardiomyocytes according to the time windows of ischaemia/reperfusion.

Authors:  Qiulin Xu; Xixian Li; Yongkang Lu; Liang Shen; Jingwen Zhang; Shiping Cao; Xiaobo Huang; Jianping Bin; Yulin Liao
Journal:  Br J Pharmacol       Date:  2015-04-10       Impact factor: 8.739

4.  Cardioprotection by adaptation to ischaemia augments autophagy in association with BAG-1 protein.

Authors:  Narasimman Gurusamy; Istvan Lekli; Nikolai V Gorbunov; Mihaela Gherghiceanu; Lawrence M Popescu; Dipak K Das
Journal:  J Cell Mol Med       Date:  2008-09-13       Impact factor: 5.310

5.  Berberine alleviates cardiac ischemia/reperfusion injury by inhibiting excessive autophagy in cardiomyocytes.

Authors:  Zhouqing Huang; Zhihua Han; Bozhi Ye; Zhenyu Dai; Peiren Shan; Zhongqiu Lu; Kezhi Dai; Changqian Wang; Weijian Huang
Journal:  Eur J Pharmacol       Date:  2015-05-21       Impact factor: 4.432

Review 6.  Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles.

Authors:  Lorenzo Galluzzi; José Manuel Bravo-San Pedro; Beth Levine; Douglas R Green; Guido Kroemer
Journal:  Nat Rev Drug Discov       Date:  2017-05-19       Impact factor: 84.694

7.  Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed mice.

Authors:  Kimberley M Mellor; James R Bell; Morag J Young; Rebecca H Ritchie; Lea M D Delbridge
Journal:  J Mol Cell Cardiol       Date:  2011-03-06       Impact factor: 5.000

8.  Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.

Authors:  Jingjing Zhang; Yanli Cheng; Junlian Gu; Shudong Wang; Shanshan Zhou; Yuehui Wang; Yi Tan; Wenke Feng; Yaowen Fu; Nicholas Mellen; Rui Cheng; Jianxing Ma; Chi Zhang; Zhanquan Li; Lu Cai
Journal:  Clin Sci (Lond)       Date:  2016-01-21       Impact factor: 6.124

9.  Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice.

Authors:  Zhonglin Xie; Kai Lau; Bonnie Eby; Pedro Lozano; Chaoyong He; Becky Pennington; Hongliang Li; Shradha Rathi; Yunzhou Dong; Rong Tian; David Kem; Ming-Hui Zou
Journal:  Diabetes       Date:  2011-05-11       Impact factor: 9.461

10.  Heart failure in the diabetic population - pathophysiology, diagnosis and management.

Authors:  Jacek Kasznicki; Jozef Drzewoski
Journal:  Arch Med Sci       Date:  2014-06-27       Impact factor: 3.318

View more
  5 in total

Review 1.  Autophagy as an emerging target in cardiorenal metabolic disease: From pathophysiology to management.

Authors:  Yingmei Zhang; Adam T Whaley-Connell; James R Sowers; Jun Ren
Journal:  Pharmacol Ther       Date:  2018-06-22       Impact factor: 12.310

2.  Metabolic Stress and Cardiovascular Disease in Diabetes Mellitus: The Role of Protein O-GlcNAc Modification.

Authors:  Yabing Chen; Xinyang Zhao; Hui Wu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-29       Impact factor: 8.311

Review 3.  Chronic O-GlcNAcylation and Diabetic Cardiomyopathy: The Bitterness of Glucose.

Authors:  Simon Ducheix; Jocelyne Magré; Bertrand Cariou; Xavier Prieur
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-29       Impact factor: 5.555

Review 4.  Current Status of Autophagy Enhancers in Metabolic Disorders and Other Diseases.

Authors:  Kihyoun Park; Myung-Shik Lee
Journal:  Front Cell Dev Biol       Date:  2022-02-14

5.  Qi-Li-Qiang-Xin Alleviates Isoproterenol-Induced Myocardial Injury by Inhibiting Excessive Autophagy via Activating AKT/mTOR Pathway.

Authors:  Cailian Fan; Xiyang Tang; Mengnan Ye; Guonian Zhu; Yi Dai; Zhihong Yao; Xinsheng Yao
Journal:  Front Pharmacol       Date:  2019-11-12       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.